CLINICAL_TRIALS
trial_result
· 2019-05-20
Clinical Trial Update: XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy [Phase 2]
Summary
Phase 2 trial evaluating XELOX in advanced biliary tract carcinoma after failure of gemcitabine-based chemotherapy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Samsung Medical Center | Conditions: Biliary Tract Cancer | Phase 2 | Status: UNKNOWN